Background: The acute loss of myocardium, following an acute myocardial infarction (AMI) leads to an abrupt increase in the loading conditions that induces a pattern of left ventricular remodeling (LVR). It has been shown that remodeling occurs rapidly and progressively within weeks after the AMI.
Study aim: The aim of our study was to identify predictors for LVR, and find correlations between them and the cardiovascular (CV) risk factors that lead to remodeling.
Material and methods: One hundred and five AMI patients who underwent primary PCI were included in the study. A 2-D echocardiography was performed at baseline (day 1 ± 3 post-MI) and at 6 months follow-up. The LV remodeling index (RI), was defined as the difference between the Left Ventricular End-Diastolic diameter (LVEDD) at 6 months and at baseline. The patients were divided into 2 groups, according to the RI: Group 1 – RI >15% with positive remodeling (n = 23); Group 2 – RI ≤15% with no remodeling (n = 82).
Results: The mean age was 63.26 ± 2.084 years for Group 1 and 59.72 ± 1.267 years for Group 2. The most significant predictor of LVR was the female gender (Group 1 – 52% vs. Group 2 – 18%, p <0.0001). Men younger than 50 years showed a lower rate of LVR (Group1 – 9% vs. Group 2 – 20%, p = 0.0432). In women, age over 65 years was a significant predictor for LVR (Group 1 – 26% vs. Group 2 – 9%, p = 0.0025). The CV risk factors associated with LVR were: smoking (p = 0.0008); obesity (p = 0.013); dyslipidemia (p = 0.1184). The positive remodeling group had a higher rate of LAD stenosis compared to the no-remodeling group (48% vs. 26%, p = 0.002). The presence of multi-vessel disease was shown to be higher in Group 1 (26% vs. 9%, p = 0.0025). The echocardiographic parameters that predicted LVR were: LVEF <45% (p = 0.048), mitral regurgitation (p = 0.022), and interventricular septum hypertrophy (p <0.0001).
Conclusions: The CV risk factors correlated with LVR were smoking, obesity and dyslipidemia. A >50% stenosis in the LAD and the presence of multi-vessel CAD were found to be significant predictors for LVR. The most powerful predictors of LVR following AMI were: LVEF <45%, mitral regurgitation, and interventricular septum hypertrophy.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Weisman HF Bush DE Mannisi JA Bulkley BH. Global Cardiac Remodeling After Acute Myocardial Infarction: A Study in the Rat Model. J Am Coll Cardiol. 1985;5(6):1355-1362.
2. Konstam MA Kramer DG Patel AR Maron MS Udelson JE. Left Ventricular Remodeling in Heart Failure Current Concepts in Clinical Significance and Assessment. JACC Cardiovasc Imaging. 2011;4(1):98-108.
3. Hutchins GM Bulkley BH. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol. 1978;41(7):1127-1132.
4. Weisman HF Healy B. Myocardial infarct expansion infarct extension and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis. 1987;30(2):73-110.
5. Sutton MG Sharpe N. Left Ventricular Remodeling After Myocardial Infarction — Pathophysiology and Therapy. Circulation. 2000;101(25):2981-2988.
6. Chareonthaitawee P Christian TF Hirose K Gibbons RJ Rumberger JA. Relation of Initial Infarct Size to Extent of Left Ventricular Remodeling in the Year After Acute Myocardial Infarction. J Am Coll Cardiol. 1995;25(3):567-573.
7. Eaton LW Weiss JL Bulkley BH Garrison JB Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med. 1979;300(2):57-62.
8. Erlebacher JA Weiss JL Eaton LW Kallman C Weisfeldt ML Bulkley BH. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am J Cardiol. 1982;49(5):1120-1126.
9. McKay RG Pfeffer MA Pasternak RC et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74(4):693-702.
10. Whittaker P Boughner DR Kloner RA. Role of collagen in acute myocardial infarct expansion. Circulation. 1991;84(5):2123-2134.
11. Chareonthaitawee P Christian TF Hirose K Gibbons RJ Rumberger JA. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol. 1995;25(3):567-573.
12. van Gilst WH Kingma JH Peels KH Dambrink JH St John Sutton M. Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). J Am Coll Cardiol. 1996;28(1):114-121.
13. Dujardin KS Enriquez-Sarano M Rossi A Bailey KR Seward JB. Echocardiographic Assessment of Left Ventricular Remodeling: Are Left Ventricular Diameters Suitable Tools? J Am Coll Cardiol. 1997;30(6):1534-1541.
14. Gottdiener JS Livengood SV Meyer PA Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol. 1995;25(2):424-430.
15. Konstam MA Kramer DG Patel AR Maron MS Udelson JE. Left Ventricular Remodeling in Heart Failure Current Concepts in Clinical Significance and Assessment. JACC Cardiovasc Imaging. 2011;4(1):98-108.
16. Marwick T. Techniques for comprehensive two dimensional echocardiographic assessment of left ventricular systolic function. Heart. 2003;89(Suppl3):iii2–iii8.
17. Mosca L Barrett-Connor E Kass Wenger N. Sex/Gender Differences in Cardiovascular Disease Prevention What a Difference a Decade Makes. Circulation. 2011;124(19):2145–2154.
18. Piro M Della Bona R Abbate A Biasucci LM Crea F. Sex-Related Differences in Myocardial Remodeling. J Am Coll Cardiol. 2010;55(11):1057-1065.
19. Ednei LA Andrey JS dos Santos AA et al. Are there gender differences in left ventricular remodeling after myocardial infarction in rats? Rev Bras Cir Cardiovasc. 2015;30(1):70–76.
20. Litwin SE Katz SE Litwin CM Morgan JP Douglas PS. Gender differences in postinfarction left ventricular remodeling. Cardiology. 1999;91(3):173-183.
21. Konstam MA Udelson JE Anand IS Cohn JN. Ventricular remodeling in heart failure: a credible surrogate endpoint. J Card Fail. 2003;9(5):350-353.
22. Zornoff LAM Matsubara BB Matsubara LS et al. Cigarette smoke exposure intensifies ventricular remodeling process following myocardial infarction. Arq Bras Cardiol. 2006;86(4):276-282
23. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321(4):225-236.
24. Messerli FH Ventura HO Reisin E et al. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation. 1982;66(1):55-60.
25. Messerli FH. Cardiomyopathy of obesity: a not-so-Victorian disease. N Engl J Med. 1986;314:378-380
26. Powell BD Redfield MM Bybee KA Freeman WK Rihal CS. Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. Am J Cardiol. 2006;98(1):116-20
27. Litwin SE. Cardiac Remodeling in Obesity Time for a New Paradigm. JACC Cardiovasc Imaging. 2010;3(3):275-7.
28. Avelar E Cloward TV Walker JM. Left Ventricular Hypertrophy in Severe Obesity Interactions Among Blood Pressure Nocturnal Hypoxemia and Body Mass. Hypertension. 2007;49(1):34-9.
29. Sorajja P Gersh BJ Cox DA et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28(14):1709-1716.
30. Park D-W Clare RM Schulte PJ et al. Extent location and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. JAMA. 2014;312(19):2019-2027.
31. Pfeffer JM Pfeffer MA Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985;57(1):84-95.
32. Pfeffer MA Lamas GA Vaughan DE Parisi AF Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319(2):80-86.
33. Sweet CS Emmert SE Stabilito II Ribeiro LG. Increased survival in rats with congestive heart failure treated with enalapril. J Cardiovasc Pharmacol. 1987;10(6):636-642.
34. Pfeffer MA Pfeffer JM Steinberg C Finn P. Survival after an experimental myocardial infarction: beneficial cfft’cts of loneterm therapy with captopril. Circulation. 1985;72(2):406-412.
35. Jugdutt BI Schwarz-Michorowski BL Khan MI. Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction. J Am Coll Cardiol. 1992;19(3):713-721.
36. Pfeffer MA1 Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161-1172.
37. Touchstone DA Beller GA Nygaard TW Tedesco C Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a topographic assessment using two-dimensional echocardiography. J Am Coll Cardiol. 1989;13(7):1506-1513.
38. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet. 1994;343(8906):1115-1122.
39. ISIS-4: a randomised factorial trial assessing early oral captopril oral mononitrate and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet. 1995;345(8951):669-685.